212Pb-DOTAM-GRPR1

N/A

Report date: 2025/11/20 16:00:43

NME

Base Information

Drug Name212Pb-DOTAM-GRPR1

Drug Alias NameLead [212Pb] -DOTAM-GRPR1

ClassificationRadiation-emitting products > Nuclides > Lead > 212PbRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionGastrin releasing peptide receptor antagonists

TargetsGastrin releasing peptide receptor

Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantUterine Cervical NeoplasmsCarcinoma, Non-Small-Cell Lung +[6]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesOrano Med Llc

China Registration ClassN/A

Develop Information

Active CompaniesOrano Med Llc

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms, Castration-ResistantUterine Cervical NeoplasmsCarcinoma, Non-Small-Cell Lung +[6]

Inactive IndicationsN/A

Other Information

ATC CodeN/A